Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Takeda Pharmaceutical Company Limited - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
TAK
New York
2830
www.takeda.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Takeda Pharmaceutical Company Limited
Change in Siegfried's Management Team
- Jul 16th, 2026 4:32 pm
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies
- Jul 16th, 2026 4:00 pm
Will Recent Setbacks Impact Growth Prospects of DNLI Stock?
- Jul 15th, 2026 11:02 am
Takeda and Indonesia partner on plasma-derived therapies
- Jul 13th, 2026 4:13 am
Moderna, Takeda and Capricor on the verge of notching big drug approvals
- Jul 13th, 2026 2:20 am
Takeda and the Indonesian Government Announce Landmark Collaboration to Strengthen Healthcare Resilience and Expand Access to Lifesaving Plasma-Derived Medicinal Products
- Jul 12th, 2026 5:00 pm
Is Recursion Pharmaceuticals (RXRX) The Best Penny Stocks According to Billioanires?
- Jul 9th, 2026 11:29 am
Is ADMA Stock's 13.5% Monthly Gain a Sign of Recovery?
- Jul 8th, 2026 12:05 pm
PTGX Stock Surges 64% in Six Months: What Is Driving the Rally?
- Jul 7th, 2026 9:15 am
Takeda Makes Fresh AI Drug Discovery Bet With Insilico Medicine
- Jul 5th, 2026 11:31 am
[Latest] Global Antidiabetic Drugs Market Size/Share Worth USD 309.84 Billion by 2035 at a 11.62% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- Jul 3rd, 2026 2:30 am
Takeda’s New AI Drug Discovery Deal With Insilico Might Change The Case For Investing In Takeda Pharmaceutical (TSE:4502)
- Jul 2nd, 2026 8:12 pm
Asian Equities Traded in the US as American Depositary Receipts Surge in Thursday Trading
- Jul 2nd, 2026 8:41 am
Insilico Medicine, Takeda partner on AI-driven drug discovery
- Jul 2nd, 2026 4:32 am
Is Takeda Pharmaceutical Company Limited (TAK) Stock Positioned for Growth After Strong LATITUDE Atlas Study Data?
- Jun 30th, 2026 7:10 am
Alkermes Faces Risk on Orexin-Related Value From Upcoming Updates, BofA Says
- Jun 29th, 2026 9:14 am
Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda
- Jun 26th, 2026 3:46 am
Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO
- Jun 24th, 2026 1:05 am
Asian Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
- Jun 23rd, 2026 8:48 am
Takeda's Zasocitinib Achieved Significantly Greater Complete Skin Clearance Than Deucravacitinib in Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations
- Jun 23rd, 2026 6:00 am
Scroll